BIOMAT Database Logo BIOMAT Database Logo

Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. 1993

K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Department of Virology, Karolinska Institute, Stockholm, Sweden.

The prognostic and protective role of antibodies mediating cellular cytotoxicity (ADCC) and neutralization was evaluated in sera of HIV-1-infected mothers and their consecutively followed children. The presence and titres of ADCC mediating and/or neutralizing antibodies in maternal sera did not predict HIV-1 infection in their respective children. No significant difference in the sera from the children was seen when comparing the presence of neutralizing antibodies between the uninfected and infected children. Stratification of the infected group according to clinical status revealed differences. Only one of 24 AIDS patients had a high neutralizing titre against IIIB. Four patients had a very low titre and the remaining had no detectable neutralizing antibodies at all. In contrast, 10/17 infected non-AIDS children had neutralizing antibodies. Similarly, no significant difference was seen when comparing the presence of ADCC-mediating antibodies between the uninfected and the infected group of children. However, a significantly higher frequency of ADCC was seen in the seropositive non-AIDS children compared with the AIDS children. This study clearly shows that the presence of antibodies mediating ADCC and neutralization in infected children, 0-2 years old, is associated with a better clinical status and delayed disease progression.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked

Related Publications

K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark.
May 2016, AIDS research and human retroviruses,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.
February 1991, AIDS (London, England),
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
February 2016, Journal of virology,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells.
August 2018, AIDS (London, England),
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Human immunodeficiency virus (HIV)-specific antibodies, neutralizing activity and antibody-dependent cellular cytotoxicity (ADCC) in the cerebrospinal fluid of HIV-infected patients.
September 1989, Journal of neuroimmunology,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
May 2019, Journal of virology,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Cellular and antibody responses directed against the HIV-1 principal neutralizing domain in HIV-1-infected children.
October 1991, AIDS research and human retroviruses,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
December 2019, mBio,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC).
January 1999, Methods in molecular medicine,
K Broliden, and E Sievers, and P A Tovo, and V Moschese, and G Scarlatti, and P A Broliden, and C Fundaro, and P Rossi
Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity.
January 2023, Cell reports,
Copied contents to your clipboard!